Evaluation of the Carcinogenic Potential of Pharmaceuticals Alastair M. MonroJames S. MacDonald Current Opinion 25 November 2012 Pages: 309 - 319
A Risk-Benefit Assessment of Natural and Synthetic Exogenous Surfactants in the Management of Neonatal Respiratory Distress Syndrome Hervé WaltiMichèle Monset-Couchard Review Article 25 November 2012 Pages: 321 - 337
Amiodarone-Induced Pulmonary Toxicity Gillian A. J. JessurunWim G. BoersmaHarry J. G. M. Crijns Review Article 25 November 2012 Pages: 339 - 344
Safety Issues in the Treatment of Paediatric Supraventricular Tachycardias Jean-Pierre PfammatterUrs Bauersfeld Review Article 25 November 2012 Pages: 345 - 356
Safety Considerations in Treating Concomitant Diseases in Patients with Asthma Loren W. Hunt Review Article 25 November 2012 Pages: 357 - 368
Can the Fatal Toxicity of Antidepressant Drugs be Predicted with Pharmacological and Toxicological Data? Nicholas A. BuckleyPeter R. McManus Original Research Article 25 November 2012 Pages: 369 - 381